164 related articles for article (PubMed ID: 18209041)
1. IFN-alpha skews monocytes into CD56+-expressing dendritic cells with potent functional activities in vitro and in vivo.
Papewalis C; Jacobs B; Wuttke M; Ullrich E; Baehring T; Fenk R; Willenberg HS; Schinner S; Cohnen M; Seissler J; Zacharowski K; Scherbaum WA; Schott M
J Immunol; 2008 Feb; 180(3):1462-70. PubMed ID: 18209041
[TBL] [Abstract][Full Text] [Related]
2. Characterization of monocyte-derived IFNalpha-generated dendritic cells.
Jacobs B; Wuttke M; Papewalis C; Fenk R; Stüssgen C; Baehring T; Schinner S; Raffel A; Seissler J; Schott M
Horm Metab Res; 2008 Feb; 40(2):117-21. PubMed ID: 18283629
[TBL] [Abstract][Full Text] [Related]
3. Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens.
Tosi D; Valenti R; Cova A; Sovena G; Huber V; Pilla L; Arienti F; Belardelli F; Parmiani G; Rivoltini L
J Immunol; 2004 May; 172(9):5363-70. PubMed ID: 15100276
[TBL] [Abstract][Full Text] [Related]
4. Effective induction of melanoma-antigen-specific CD8+ T cells via Vγ9γδT cell expansion by CD56(high+) Interferon-α-induced dendritic cells.
Nieda M; Terunuma H; Eiraku Y; Deng X; Nicol AJ
Exp Dermatol; 2015 Jan; 24(1):35-41. PubMed ID: 25363560
[TBL] [Abstract][Full Text] [Related]
5. Monocyte-derived dendritic cells generated after a short-term culture with IFN-alpha and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response.
Santodonato L; D'Agostino G; Nisini R; Mariotti S; Monque DM; Spada M; Lattanzi L; Perrone MP; Andreotti M; Belardelli F; Ferrantini M
J Immunol; 2003 May; 170(10):5195-202. PubMed ID: 12734367
[TBL] [Abstract][Full Text] [Related]
6. Interferon-α-inducible Dendritic Cells Matured with OK-432 Exhibit TRAIL and Fas Ligand Pathway-mediated Killer Activity.
Koya T; Yanagisawa R; Higuchi Y; Sano K; Shimodaira S
Sci Rep; 2017 Feb; 7():42145. PubMed ID: 28191816
[TBL] [Abstract][Full Text] [Related]
7. IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities.
Mohty M; Vialle-Castellano A; Nunes JA; Isnardon D; Olive D; Gaugler B
J Immunol; 2003 Oct; 171(7):3385-93. PubMed ID: 14500632
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential.
Anguille S; Lion E; Tel J; de Vries IJ; Couderé K; Fromm PD; Van Tendeloo VF; Smits EL; Berneman ZN
PLoS One; 2012; 7(12):e51851. PubMed ID: 23284789
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cell vaccination induces tumor epitope-specific Th1 immune response in medullary thyroid carcinoma.
Papewalis C; Wuttke M; Jacobs B; Domberg J; Willenberg H; Baehring T; Cupisti K; Raffel A; Chao L; Fenk R; Seissler J; Scherbaum WA; Schott M
Horm Metab Res; 2008 Feb; 40(2):108-16. PubMed ID: 18283628
[TBL] [Abstract][Full Text] [Related]
10. Interferon alpha induces generation of semi-mature dendritic cells with high pro-inflammatory and cytotoxic potential.
Leplina OY; Tyrinova TV; Tikhonova MA; Ostanin AA; Chernykh ER
Cytokine; 2015 Jan; 71(1):1-7. PubMed ID: 25174880
[TBL] [Abstract][Full Text] [Related]
11. [Generation of T cell-mediated antitumor response in vitro by autologous dendritic cells pulsed with tumor lysates in patients with non-small cell lung cancer].
You J; Yu JP; Ren XB; Wang CL; Zhang P; Zhang XZ
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):333-6. PubMed ID: 15312341
[TBL] [Abstract][Full Text] [Related]
12. The involvement of TNF-alpha-related apoptosis-inducing ligand in the enhanced cytotoxicity of IFN-beta-stimulated human dendritic cells to tumor cells.
Liu S; Yu Y; Zhang M; Wang W; Cao X
J Immunol; 2001 May; 166(9):5407-15. PubMed ID: 11313377
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T lymphocytes induced by dendritic cells.
Xu JJ; Yao K; Yu CJ; Chen X; Lu MP; Sun H; Li BZ; Ding CN; Zhou F
Auris Nasus Larynx; 2006 Dec; 33(4):441-6. PubMed ID: 16934422
[TBL] [Abstract][Full Text] [Related]
14. Induction of CD83+CD14+ nondendritic antigen-presenting cells by exposure of monocytes to IFN-alpha.
Gerlini G; Mariotti G; Chiarugi A; Di Gennaro P; Caporale R; Parenti A; Cavone L; Tun-Kyi A; Prignano F; Saccardi R; Borgognoni L; Pimpinelli N
J Immunol; 2008 Sep; 181(5):2999-3008. PubMed ID: 18713970
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic activity of human dendritic cells is differentially regulated by double-stranded RNA and CD40 ligand.
Vidalain PO; Azocar O; Yagita H; Rabourdin-Combe C; Servet-Delprat C
J Immunol; 2001 Oct; 167(7):3765-72. PubMed ID: 11564793
[TBL] [Abstract][Full Text] [Related]
16. Identification of CD56
Watanabe A; Togi M; Koya T; Taniguchi M; Sakamoto T; Iwabuchi K; Kato T; Shimodaira S
Genes Cells; 2021 May; 26(5):313-327. PubMed ID: 33662167
[TBL] [Abstract][Full Text] [Related]
17. Functional repertoire of dendritic cells generated in granulocyte macrophage-colony stimulating factor and interferon-alpha.
Della Bella S; Nicola S; Riva A; Biasin M; Clerici M; Villa ML
J Leukoc Biol; 2004 Jan; 75(1):106-16. PubMed ID: 14525963
[TBL] [Abstract][Full Text] [Related]
18. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy for medullary thyroid carcinoma by dendritic cell vaccination.
Schott M; Seissler J; Lettmann M; Fouxon V; Scherbaum WA; Feldkamp J
J Clin Endocrinol Metab; 2001 Oct; 86(10):4965-9. PubMed ID: 11600571
[TBL] [Abstract][Full Text] [Related]
20. Interferon-alpha (IFN-alpha)-conditioned DC preferentially stimulate type-1 and limit Treg-type in vitro T-cell responses from RCC patients.
Gigante M; Mandic M; Wesa AK; Cavalcanti E; Dambrosio M; Mancini V; Battaglia M; Gesualdo L; Storkus WJ; Ranieri E
J Immunother; 2008 Apr; 31(3):254-62. PubMed ID: 18317362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
